Iridian Asset Management LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Iridian Asset Management LLC
- $422 Million
- Q2 2024
A detailed history of Iridian Asset Management LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 23,234 shares of DNA stock, worth $187,963. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,234
Previous 23,234
-0.0%
Holding current value
$187,963
Previous $26,000
73.08%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DNA
# of Institutions
346Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.16 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.12 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.09 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$565 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$340 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.4B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...